{"id":"https://openalex.org/W1638895111","doi":null,"title":"A systematic review to evaluate the effectiveness of enzyme replacement therapy for lysosomal storage disorders in comparison to the treatment of similar diseases with higher prevalence","display_name":"A systematic review to evaluate the effectiveness of enzyme replacement therapy for lysosomal storage disorders in comparison to the treatment of similar diseases with higher prevalence","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W1638895111","mag":"1638895111"},"language":"en","primary_location":{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/3538429b-e8a6-4133-926b-fd361b1beefc","doi":null,"is_oa":false,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/3538429b-e8a6-4133-926b-fd361b1beefc","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Rare diseases and orphan drugs, 1(2), 38 - 56","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066388523","display_name":"Shona Lang","orcid":"https://orcid.org/0000-0002-4883-8393","observed_orcids":["https://orcid.org/0000-0002-4883-8393"]},"institutions":[{"id":"https://openalex.org/I4210088647","display_name":"Kleijnen Systematic Reviews (United Kingdom)","ror":"https://ror.org/004g82f36","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210088647"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lang, S.H.","raw_affiliation_strings":["Kleijnen Systematic Reviews Ltd.,#R##N#Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kleijnen Systematic Reviews Ltd.,#R##N#Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD","institution_ids":["https://openalex.org/I4210088647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059685514","display_name":"Nigel Armstrong","orcid":"https://orcid.org/0000-0002-7443-4798","observed_orcids":["https://orcid.org/0000-0002-7443-4798"]},"institutions":[{"id":"https://openalex.org/I4210088647","display_name":"Kleijnen Systematic Reviews (United Kingdom)","ror":"https://ror.org/004g82f36","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210088647"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Armstrong, N.","raw_affiliation_strings":["Kleijnen Systematic Reviews Ltd.,#R##N#Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kleijnen Systematic Reviews Ltd.,#R##N#Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD","institution_ids":["https://openalex.org/I4210088647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051240644","display_name":"Caro Noake","orcid":"https://orcid.org/0000-0003-0329-4772","observed_orcids":["https://orcid.org/0000-0003-0329-4772"]},"institutions":[{"id":"https://openalex.org/I4210088647","display_name":"Kleijnen Systematic Reviews (United Kingdom)","ror":"https://ror.org/004g82f36","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210088647"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Noake, C.","raw_affiliation_strings":["Kleijnen Systematic Reviews Ltd.,#R##N#Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kleijnen Systematic Reviews Ltd.,#R##N#Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD","institution_ids":["https://openalex.org/I4210088647"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065584931","display_name":"Jos Kleijnen","orcid":"https://orcid.org/0000-0003-2787-7091","observed_orcids":["https://orcid.org/0000-0003-2787-7091","https://orcid.org/0000-0001-8413-2366"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kleijnen, J.","raw_affiliation_strings":["Huisartsgeneeskunde"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huisartsgeneeskunde","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2532,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.5307748,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enzyme-replacement-therapy","display_name":"enzyme replacement therapy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lysosomal-storage-disorders","display_name":"lysosomal storage disease","score":0.9950000047683716},{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.800000011920929},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.8199999928474426},{"id":"https://openalex.org/keywords/number-needed-to-benefit","display_name":"number needed to benefit","score":0.8700000047683716},{"id":"https://openalex.org/keywords/clinical-effectiveness","display_name":"clinical effectiveness","score":0.777999997138977},{"id":"https://openalex.org/keywords/reimbursement","display_name":"reimbursement","score":0.38100001215934753},{"id":"https://openalex.org/keywords/fabry-disease","display_name":"Fabry disease","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hunter-syndrome","display_name":"Hunter syndrome","score":0.9290000200271606},{"id":"https://openalex.org/keywords/gaucher-disease-type-1","display_name":"Gaucher disease type 1","score":0.9779999852180481},{"id":"https://openalex.org/keywords/value-for-money","display_name":"value for money","score":0.5809999704360962},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.5699999928474426},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9850000143051147},{"id":"https://openalex.org/keywords/peripheral-arterial-disease","display_name":"peripheral arterial disease","score":0.9599999785423279},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.574999988079071},{"id":"https://openalex.org/keywords/nice","display_name":"Nice","score":0.5450000166893005},{"id":"https://openalex.org/keywords/iqwig","display_name":"IQWiG","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8438153266906738},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.5638346672058105},{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.5618349313735962},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.5268805623054504},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5175737142562866},{"id":"https://openalex.org/C2779969927","wikidata":"https://www.wikidata.org/wiki/Q916766","display_name":"Enzyme replacement therapy","level":3,"score":0.5112400054931641},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.4987609386444092},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4607802927494049},{"id":"https://openalex.org/C133925201","wikidata":"https://www.wikidata.org/wiki/Q188419","display_name":"Life expectancy","level":3,"score":0.4539591372013092},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.44840526580810547},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4416372776031494},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.43475210666656494},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4259316623210907},{"id":"https://openalex.org/C2777404818","wikidata":"https://www.wikidata.org/wiki/Q615645","display_name":"Fabry disease","level":3,"score":0.4153413474559784},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4017089009284973},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3517700135707855},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3202916383743286},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31639713048934937},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.24282458424568176},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.19170233607292175},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.15079304575920105},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/3538429b-e8a6-4133-926b-fd361b1beefc","doi":null,"is_oa":false,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/3538429b-e8a6-4133-926b-fd361b1beefc","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Rare diseases and orphan drugs, 1(2), 38 - 56","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W105501628","https://openalex.org/W1498792700","https://openalex.org/W1589127617","https://openalex.org/W1900339045","https://openalex.org/W1939260248","https://openalex.org/W1964199934","https://openalex.org/W1982900907","https://openalex.org/W1987609279","https://openalex.org/W1988295507","https://openalex.org/W1993027304","https://openalex.org/W2022356406","https://openalex.org/W2023560805","https://openalex.org/W2034511507","https://openalex.org/W2051575509","https://openalex.org/W2070884008","https://openalex.org/W2085053807","https://openalex.org/W2093722439","https://openalex.org/W2108096958","https://openalex.org/W2108650270","https://openalex.org/W2119790985","https://openalex.org/W2120240121","https://openalex.org/W2123374032","https://openalex.org/W2125879510","https://openalex.org/W2132265655","https://openalex.org/W2139927163","https://openalex.org/W2140965629","https://openalex.org/W2148045371","https://openalex.org/W2158058290","https://openalex.org/W2313827278","https://openalex.org/W2325794768","https://openalex.org/W2509949587"],"related_works":["https://openalex.org/W4296456405","https://openalex.org/W2071543365","https://openalex.org/W2023560805","https://openalex.org/W1523209662","https://openalex.org/W7115391437","https://openalex.org/W1965378769","https://openalex.org/W2078569420","https://openalex.org/W2905765430","https://openalex.org/W2115647336","https://openalex.org/W1788182075"],"abstract_inverted_index":{"Significant":[0],"challenges":[1],"exist":[2],"when":[3],"submitting":[4],"orphan":[5,350],"drugs":[6,40,71,315,351,354],"for":[7,18,64,72,194,230,273,295,299,306,316,363],"reimbursement":[8,364],"in":[9,108,215,219,223,254],"a":[10,49],"health":[11],"care":[12],"system.":[13],"An":[14],"assessment":[15],"of":[16,29,35,59,69,105,133,139,143,145,147,155,198,290,326,336,343,349],"value":[17,289],"money":[19],"is":[20],"undertaken":[21],"by":[22,334],"comparing":[23],"the":[24,30,56,84,159,178,195,235,274,324,330,341,347],"costs":[25],"and":[26,118,127,158,266,340],"clinical":[27,57,360],"effectiveness":[28,58,348,361],"new":[31,50],"technology":[32],"to":[33,47,54,67,83,89,99,170,185,243,281,323],"that":[34,68,303],"an":[36],"existing":[37,313],"treatment.":[38],"Orphan":[39],"rarely":[41],"have":[42],"standard":[43],"treatments,":[44],"with":[45,352],"which":[46],"contrast":[48],"technology.":[51],"We":[52,173],"aimed":[53],"compare":[55],"enzyme":[60],"replacement":[61],"therapy":[62],"(ERT)":[63],"rare":[65,110,307],"diseases,":[66],"recommended":[70,314],"comparable":[73,317],"but":[74],"non-rare":[75],"diseases":[76,308],"(lifelong":[77],"treatment,":[78],"shortened":[79],"life":[80],"expectancy":[81],"due":[82],"disease),":[85],"using":[86,355],"number":[87],"needed":[88],"benefit":[90],"(NNTB).":[91],"A":[94],"systematic":[95],"review":[96],"was":[97,293],"performed":[98,193,229,272],"identify":[100],"randomised":[101],"controlled":[102],"trials":[103],"(RCTs)":[104],"ERT":[106,210,296,304],"treatments":[107],"three":[109],"diseases;":[111],"Fabry":[112,216],"Disease,":[113,217],"Hunter":[114,220],"Syndrome":[115],"(MPS":[116],"II)":[117],"Gaucher":[119,224],"Disease":[120],"Type":[121],"1.":[122],"MEDLINE,":[123],"MEDLINE":[124],"In-Process":[125],"Citations":[126],"Daily":[128],"Update,":[129],"EMBASE,":[130],"Cochrane":[131,136],"Database":[132,142],"Systematic":[134],"Reviews,":[135],"Central":[137],"Register":[138],"Controlled":[140,156],"Trials,":[141],"Abstracts":[144],"Reviews":[146],"Effects,":[148],"Health":[149],"Technology":[150],"Assessment":[151],"Database,":[152],"ClinicalTrials.gov,":[153],"metaRegister":[154],"Trials":[157,163],"WHO":[160],"International":[161],"Clinical":[162],"Registry":[164],"Platform":[165],"were":[166,192,212,228,252,271,309,332],"searched":[167],"from":[168,177,234,241,279],"inception":[169],"August":[171],"2012.":[172,186],"identified":[174,213,253],"comparator":[175,249,275,300],"studies":[176,251,297],"NICE":[179],"(UK)":[180],"or":[181],"IQWiG/G-BA":[182],"(Germany),":[183],"websites":[184],"For":[187],"each":[188],"study,":[189],"NNTB":[190,232,277,291,356],"analyses":[191,227,270,331],"primary":[196],"outcome":[197],"all":[199,204],"(recommended)":[200],"drug":[201],"doses,":[202],"at":[203],"follow-up":[205],"times.":[206],"Ten":[209],"RCTs":[211],"(8":[214],"2":[218,260],"Syndrome,":[221],"0":[222],"Disease).":[225],"Eleven":[226],"ERTs;":[231],"calculated":[233],"mean":[236],"absolute":[237],"risk":[238,335],"difference":[239],"ranged":[240,278],"1.4":[242],"17.2":[244],"(median":[245,283],"=":[246,284],"2.7).":[247],"Seven":[248],"disease":[250,265],"multiple":[255],"sclerosis,":[256],"rheumatoid":[257],"arthritis,":[258],"type":[259],"diabetes":[261],"mellitus,":[262],"peripheral":[263],"arterial":[264],"Alzheimer":[267],"disease.":[268],"Thirty-nine":[269],"studies;":[276],"-61.8":[280],"330.8":[282],"4.6).":[285],"The":[287],"median":[288],"values":[292],"lower":[294],"than":[298,312],"studies,":[301],"suggesting":[302],"therapies":[305],"more":[310],"effective":[311],"diseases.":[318],"Caution":[319],"should":[320],"be":[321],"applied":[322],"interpretation":[325],"these":[327],"results":[328],"because":[329],"limited":[333],"bias,":[337],"study":[338],"size":[339],"lack":[342],"identical":[344],"outcomes.":[345],"Comparing":[346],"non-orphan":[353],"may":[357],"provide":[358],"additional":[359],"information":[362],"decision":[365],"making.":[366]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}